40
Participants
Start Date
October 31, 2006
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
ATG-Fresenius S
"Dosage: Single high-dose of 9 mg/kg pre-operatively, followed by 3 mg/kg/d at day +2 and +4. ATG-Fresenius treatment at Days 0, +2, and +4 is mandatory.~(In case of persisting DGF, the treatment is left to the discretion of the investigator. Treatment options include the continuation of ATG-Fresenius treatment with 3 mg/kg/d at Day +6 and if deemed necessary also at Day +8 - but without corticosteroids)."
Hospital Universitario Juan Canalejo, A Coruña
Hosptial Gregorio Maranon, Madrid
Fundación Jiménez Díaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Centro Hospitalar de Lisboa Ocidental, Carnaxide
Hospitais da Universidade de Coimbra, Coimbra
Hospital de Curry Cabral, Lisbon
Hospital Geral de Santo António, SA, Porto
Hospital Universitari Clinic i Provincial, Barcelona
Lead Sponsor
Eurotrials Brasil Consultores Cientificos Ltda
INDUSTRY
Recerca Clínica S.L.
INDUSTRY
PsyConsult
UNKNOWN
Neovii Biotech
INDUSTRY